Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.62 |
| ▸ | CTSL | P07711 | 5/20 | 0.62 |
| ▸ | CTSS | P25774 | 4/20 | 0.62 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | ECE1 | P42892 | 1/20 | 0.51 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6825553 | 0.92 | CAPN1 (0.54) | CTSKCTSLCTSSCAPN1F2 | |
| SCHEMBL6829949 | 0.87 | CAPN1 (0.55) | CTSKCTSLCTSSCAPN1MME | |
| SCHEMBL8710241 | 0.86 | CAPN1 (0.61) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL6828393 | 0.85 | CAPN1 (0.63) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL6825605 | 0.85 | CAPN1 (0.63) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL6828120 | 0.85 | CAPN1 (0.63) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL8710235 | 0.85 | CAPN1 (0.60) | CTSKCTSLCTSSCAPN1CTSB | |
| Hydrochloric Acid SCHEMBL6828093 | 0.85 | CAPN1 (0.60) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL6828119 | 0.85 | CAPN1 (0.62) | CTSKCTSLCTSSCAPN1CTSB | |
| SCHEMBL6828697 | 0.84 | CAPN1 (0.58) | CTSKCTSLCTSSCAPN1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1389624-A1 | Phosphorous-containing cysteine and serine protease inhibitors | CEPHALON, INC. (US) | 2004-02-18 | — | — | EP | disclosed |
| EP-0871454-A4 | — | — | 1998-11-25 | — | — | EP | disclosed |
| EP-0871454-A1 | PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON, INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5639732-A | FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT | CEPHALON, INC. (US) | 1997-06-17 | — | — | US | disclosed |
| WO-1997003679-A1 | PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON, INC. (US) | 1997-02-06 | — | — | WO | disclosed |